CoChat

Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma

Open access
Liu, Zhichao, Zhang, Yaru, Ma, Ning, Yang, Yang, Ma, Yunlong, Wang, Feng, Wang, Yan, Wei, Jinzhi, Chen, Hongyan, Tartarone, Alfredo, Velotta, Jeffrey B., Dayyani, Farshid, Gabriel, Emmanuel, Wakefield, Connor J., Kidane, Biniam, Carbonelli, Cristiano, Long, Lingyun, Liu, Zhihua, Su, Jianzhong, Li, Zhigang · 2023 · Cancer Cell
Cited by 182

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Neoadjuvant immune checkpoint blockade (ICB) demonstrates promise in operable esophageal squamous cell carcinoma (ESCC), but lacks available efficacy biomarkers. Here, we perform single-cell RNA-sequencing of tumors from patients with ESCC undergoing neoadjuvant ICB, revealing a subset of exhausted CD8+ T cells expressing SPRY1 (CD8+ Tex-SPRY1) that displays a progenitor exhausted T cell (Tpex) phenotype and correlates with complete response to ICB. We validate CD8+ Tex-SPRY1 cells as an ICB-specific predictor of improved response and survival using independent ICB-/non-ICB cohorts and demonstrate that expression of SPRY1 in CD8+ T cells enforces Tpex phenotype and enhances ICB efficacy. Additionally, CD8+ Tex-SPRY1 cells contribute to proinflammatory phenotype of macrophages and functional state of B cells, which thereby promotes antitumor immunity by enhancing CD8+ T cell effector functions. Overall, our findings unravel progenitor-like CD8+ Tex-SPRY1 cells’ role in effective responses to ICB for ESCC and inform mechanistic biomarkers for future individualized immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2023.09.011

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Metadata

Authors
Liu, Z., Zhang, Y., Ma, N., Yang, Y., Ma, Y., Wang, F., Wang, Y., Wei, J., Chen, H., Tartarone, A., Velotta, J. B., Dayyani, F., Gabriel, E., Wakefield, C. J., Kidane, B., Carbonelli, C., Long, L., Liu, Z., Su, J., & Li, Z.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2023-11
Volume
41
Issue
11
Pages
1852-1870.e9
ISSN
1535-6108 (ISSN-L)
OpenAlex
W4387579013
Cited by
182
References
34
FWCI
19.57
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.